Table 5.
Characteristics | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 |
---|---|---|---|---|---|---|
Demographics | ||||||
Age/gender | 43/male | 44/male | 54/male | 58/male | 44/male | 57/female |
Non invasive markers | ||||||
APRI score | 0.326 | 1.013 | 0.447 | 0.255 | 0.243 | 0.15 |
FIB4 score | 0.66 | 2.64 | 1.46 | 0.85 | 0.63 | 0.98 |
TE parameters | ||||||
Liver stiffness (kPa) | 8.6 | 9.9 | 7.6 | 12 | 7.9 | 9.1 |
CAP | 364 | 320 | 360 | - | 231 | 375 |
Biopsy | ||||||
Fragment size (mm) | 1.6 ×0.1 ×0.1 | 1.5 ×0.1 ×0.1 | 1.7 ×0.1 ×0.1 | 1.6 ×0.1 ×0.1 | 1.3 ×0.1 ×0.1 | 1.6 ×0.1 ×0.1 |
Histologic diagnosis |
NASH Fibrosis F0 |
Without NASH Fibrosis F1 |
NASH Fibrosis F0 |
NASH Fibrosis F0 |
NASH Fibrosis F1 |
NASH Fibrosis F1 |
Abbreviations: FIB-4, fibrosis-4; APRI, AST to platelet ratio index; CAP, controlled attenuation parameter; NASH, nonalcoholic steatohepatitis.